HIGHLIGHTS
- who: PI et al. from the Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz have published the paper: Rhabdomyolysis-Induced AKI (RIAKI) Including the Role of COVID-19, in the Journal: (JOURNAL) of 22/07/2022
- how: Although the authors emphasize that the mechanism of SAMS is unclear the following theories are proposed as shown in Table 4 .
SUMMARY
The most important medications that can cause skeletal muscle-associated symptoms (SAMS), including the most severe form, rhabdomyolysis, are statins. The most serious complication is AKI, which develops in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.